This hub covers epilepsy comorbidities, which are the other conditions that often show up alongside seizures (like ADHD, anxiety, depression, autism, and sleep issues). Plain-language research takeaways for families.
Often both. Shared brain networks, stress, sleep disruption, and medication effects can all contribute.
Track timing: New symptoms after med changes or dose increases may point to side effects.
If school is hard, attention/memory changes, or there’s concern about learning, yes, it can guide supports.
Sometimes. Improving sleep and stress can reduce seizure susceptibility in some people.
Researchers conducted a systematic review and network meta-analysis to compare the effectiveness of various non-drug treatments for anxiety, depression, and quality of life in people with epilepsy.
Researchers conducted a study to evaluate the effectiveness of a medication called fremanezumab in treating patients who experience migraines and also have major depressive disorder.
Researchers conducted a study to understand how effective first-line antiseizure medications (ASMs) are for children newly diagnosed with epilepsy.
Researchers investigated the use of intravenous (i/v) levetiracetam (LEV) as a first-line treatment for patients experiencing non-convulsive status epilepticus (NCSE), a serious condition where seizures occur without noticeable convulsions.
Researchers studied how problems with the glymphatic system, which helps clear waste from the brain, might affect cognitive decline in elderly patients with late-onset epilepsy (LOE) who also have chronic insomnia.
Researchers studied how depression and suicidal thoughts change over time in adults with epilepsy who initially had high scores on a depression screening tool called the Neurological Disorders Depression Inventory for Epilepsy (NDDI-E).
Researchers studied the long-term risks of dementia and death in older veterans who have experienced traumatic brain injury (TBI).
Researchers examined how much revenue neurologists generate after patients visit them for specific neurological conditions, such as epilepsy and multiple sclerosis.
Researchers examined the use of vagus nerve stimulation (VNS) as a treatment for immune diseases, in addition to its established role in managing neurological conditions like epilepsy and depression.